Adaptive Biotechnologies Corp vs TotalEnergies SE — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while TotalEnergies SE trades at $87.22 (market cap $196.06B). The key difference: TotalEnergies SE is far larger — about 48.5× Adaptive Biotechnologies Corp's market cap, and TotalEnergies SE pays a 4.82% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | TTE | |
|---|---|---|
Market Cap | $4.04B | $196.06B |
Sector | Health | Energy |
52-Week High | $25.45 | $93.60 |
52-Week Low | $12.30 | $57.39 |
Enterprise Value | $4.10B | $227.06B |
Dividend Yield | — | 4.82% |
Trailing returns across standard periods
Latest headlines on both assets
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.5 million barrels of liquids and 7.2 billion cubic feet of natural gas per day. At year-end 2020, reserves stood at 12.1 billion barrels of oil equivalent, 45% of which are liquids. During 2021, it had LNG sales of 42 Mt. The company owns interests in refineries with capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. It also holds a 19% interest in Russian oil company Novatek. At year-end, its gross installed renewable power generation capacity was 10.3 GW.
Read more on TTE →